19 May 2015

Pharmaceuticals: drug development

Organised by:

SCI's Food Group in collaboration with Acumentia and Vital Six and supported by SCI's Fine Chemicals Group

Science & Technology Centre University of Reading

Registration Closed

This event is no longer available for registration.

Programme
Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact

University of Reading

Science & Technology Centre
University of Reading
Earley Gate 
Whiteknights Road 
Reading RG6 6BZ 
For a location map click here

Susan Elliott

Tel: 0118 935 7115

Email: susan.elliott@vitalsix.co.uk

Fees
Free

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Accredited cpd Centre - The CPD Standards Office - CPD Provider 41057 - www.cpdstandards.com

Partners
Additional Info

TBC

Keynote Speakers

Prof Helen Osborn, Head of Pharmacy/Chemistry at University of Reading, will talk about her work on developing drugs for cancer and diabetes amongst other things.

Dr Derek Clissold, MD of LipidEv Ltd, will talk about a new class of lipid based anti-inflammatory drugs his company is developing.

Prof Barbara Mulloy, Imperial College, will talk about how, in conjunction with FDA they tackled a serious incident of illegal contamination of Heparin (major drug used in open heart surgery).

 

Event partners: Acumentia and Vitalsix